Feng Bao, Chai Xin, Yu Yi, Xia Hao, Wu Junyi, Ren Yin, Yu PeiMin, Zhu Yufu
First Clinical Medical College of Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou, 221004, China.
Department of Neurosurgery, Shanting District People's Hospital of Zaozhuang City, No. 528 Beijing Road, Zaozhuang, 277200, China.
Sci Rep. 2025 Mar 25;15(1):10289. doi: 10.1038/s41598-025-94797-2.
This study aimed to investigate the clinical efficacy and early outcomes of endoscopic microvascular decompression (MVD) for primary trigeminal neuralgia (TN) and provide clinical experience for the application of full endoscopic techniques in MVD surgery.
This study retrospectively collected medical records of patients who underwent microvascular decompression (MVD) surgery at our institution between January 2020 and January 2023. According to predefined inclusion and exclusion criteria, a total of 137 patients were ultimately included in the study. To evaluate the severity of facial pain in these patients, we utilized the Barrow Neurological Institute (BNI) pain intensity rating system. Additionally, this study analyzed and compared the clinical outcomes of MVD procedures performed endoscopically versus those performed under microscopy.
There were no statistically significant differences between endoscopic and microscopic microvascular decompression (MVD) in terms of postoperative hospital stay, recurrence rate, complication incidence, and surgical duration (P > 0.05). However, regarding the efficacy of treatment, the effectiveness rate after endoscopic MVD was superior to that of microscopic MVD, with a statistically significant difference observed between the two groups (P < 0.05).
Endoscopic microvascular decompression (MVD) for primary trigeminal neuralgia is a safe and effective treatment, with the critical success factor being the accurate localization of the vessel compressing the nerve. Compared to traditional microscopic MVD, endoscopic MVD shows superior postoperative outcomes, offering wide-angle and multi-angle views along with close-up inspection capabilities. However, it requires attention to overcoming limitations such as a lack of stereoscopic vision and potential blind spots.
本研究旨在探讨内镜下微血管减压术（MVD）治疗原发性三叉神经痛（TN）的临床疗效和早期预后，并为全内镜技术在MVD手术中的应用提供临床经验。
本研究回顾性收集了2020年1月至2023年1月在我院接受微血管减压术（MVD）的患者的病历。根据预先定义的纳入和排除标准，最终共有137例患者纳入研究。为评估这些患者面部疼痛的严重程度，我们采用了巴罗神经学研究所（BNI）疼痛强度评分系统。此外，本研究分析并比较了内镜下与显微镜下进行MVD手术的临床结果。
内镜下微血管减压术（MVD）与显微镜下微血管减压术在术后住院时间、复发率、并发症发生率和手术时长方面无统计学显著差异（P＞0.05）。然而，在治疗效果方面，内镜下MVD术后有效率优于显微镜下MVD，两组间差异有统计学意义（P＜0.05）。
内镜下微血管减压术（MVD）治疗原发性三叉神经痛是一种安全有效的治疗方法，关键成功因素是准确定位压迫神经的血管。与传统显微镜下MVD相比，内镜下MVD术后效果更佳，具有广角和多角度视野以及近距离观察能力。然而，需要注意克服诸如缺乏立体视觉和潜在盲点等局限性。
